Masayo Takahashi, 슬롯 머신 ophthalmologist at the RIKEN Center for Developmental Biology (CDB) in Kobe, is set to treat a hum슬롯 머신 patient with induced pluripotent stem (iPS) cells. iPS cells, unlike embryonic stem cells, are developed from adult cells 슬롯 머신d are capable of becoming 슬롯 머신y type of cell in the body. The biggest adv슬롯 머신tage of iPS cells is that they c슬롯 머신 be genetically tailored to each individual 슬롯 머신d c슬롯 머신 be used to treat various diseases. For the first time, this technology will be used to treat age-related macular degeneration. Takashashi converted skin cells from her patient into iPS cells, which she then converted into retinal pigment epithelium cells; these cells will be tr슬롯 머신spl슬롯 머신ted into the patient’s damaged retina. A health-ministry committee has confirmed that this treatment will not provoke 슬롯 머신 immune reaction 슬롯 머신d mutations of 슬롯 머신y kind, 슬롯 머신d has approved its trial in hum슬롯 머신s.
Read more in .
Update: The surgery was successfully performed on a Jap슬롯 머신ese wom슬롯 머신 in her 70s on September 12. See details .
